Randomized Double-blind Parallel Trial to Evaluate Equivalence in Efficacy and Safety of HD203 and Enbrel in RA Patients
Clinical trial NCT01270997 · COMPLETED
Trial details
- NCT number
- NCT01270997
- Sponsor
- Hanwha Chemical
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2012-05-01
- Enrollment
- 294
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.